Relypsa, Inc. is a late clinical-stage pharmaceutical company leading the discovery and development of novel non-absorbed polymeric drugs for important applications in cardiovascular and renal diseases. Relypsa's lead product candidate is patiromer,...
Portola Pharmaceuticals, Inc.
South San Francisco,
Portola Pharmaceuticals, Inc. was founded in 2003 and is headquartered in South San Francisco, CA. We completed an initial public offering in May 2013 and are traded on the Nasdaq Stock Market under the symbol PTLA. We have approximately 85...
CONTRACTS ADMINISTRATOR/EXECUTIVE ASSISTANT
Ignyta, Inc., a trailblazing biotechnology company catalyzing personalized medicine in cancer, has an outstanding opportunity for a Contracts Administrator/Executive Assistant. We are pursuing an...